SCANDIGEN LAB AS

SCANDIGEN LAB AS is registered as a limited company in Hamar, Innlandet with organisation number 926894455. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2021. Registered share capital is NOK 500,000, divided into 500000 shares. The company's stated purpose is: “Drive virksomhet i Norge, Sverige og Finland basert på gentesting og uthenting av DNA fra planter og dyr, samt det som naturlig står i forbindelse med slik testing og/eller uthenting.”. The most recent filed accounts, for the 2024 financial year, show NOK 2.2m in revenue and NOK 725,000 in operating profit.

Key figures · 2024

Revenue

NOK 2.2m

Operating profit

NOK 725,000

Equity

NOK 1.2m

Est. value

NOK 2.9m

Financial health · 2024

Liquidity

7.09

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

39.5%

Good

Equity as a share of total capital

Who owns SCANDIGEN LAB AS?

DR. VAN HAERING GLOBAL B.V.

50.0%

SCANDIGEN LAB AS

NOK 2.2m rev. · NOK 725,000 profit

SCANDIGEN LAB AS has 2 registered shareholders:

• DR. VAN HAERING GLOBAL B.V. 50.0%
• BIOBANK AS 50.0%

All shareholders and roles →

Frequently asked questions about SCANDIGEN LAB AS

Who owns SCANDIGEN LAB AS?

DR. VAN HAERING GLOBAL B.V. is the largest registered owner, with 50.0%.

What is the revenue of SCANDIGEN LAB AS?

SCANDIGEN LAB AS had revenue of NOK 2.2m in 2024.

Who is the general manager of SCANDIGEN LAB AS?

Laila Bekk is registered as general manager of SCANDIGEN LAB AS.

Where is SCANDIGEN LAB AS based?

SCANDIGEN LAB AS has its business address in Hamar.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.